• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cyclophosphamide, methotrexate, and 5-FU (CMF)-induced nausea and vomiting: a controlled study with high-dose metoclopramide.

作者信息

David M, Durand M, Chauvergne J, Mauriac L, Bui B N, Hoerni B

出版信息

Cancer Treat Rep. 1984 Jun;68(6):921-2.

PMID:6547368
Abstract
摘要

相似文献

1
Cyclophosphamide, methotrexate, and 5-FU (CMF)-induced nausea and vomiting: a controlled study with high-dose metoclopramide.环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）所致恶心和呕吐：一项高剂量甲氧氯普胺的对照研究
Cancer Treat Rep. 1984 Jun;68(6):921-2.
2
Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma.
Cancer Treat Rep. 1982 Aug;66(8):1601-4.
3
Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study.甲泼尼龙与甲氧氯普胺预防接受静脉注射环磷酰胺、甲氨蝶呤和5-氟尿嘧啶治疗的乳腺癌患者恶心呕吐的疗效比较：一项双盲随机研究
Oncology. 1988;45(5):346-9. doi: 10.1159/000226638.
4
[Use of dexamethasone as an antiemetic in patients with breast cancer treated with the CMF regimen].
Przegl Lek. 1994;51(5):203-5.
5
Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.低剂量口服格拉司琼加地塞米松与高剂量甲氧氯普胺加地塞米松预防年轻非霍奇金淋巴瘤患者CHOP化疗所致恶心呕吐的比较研究
J Med Assoc Thai. 2002 Nov;85(11):1156-63.
6
[Incidence of emesis in outpatients on chemotherapy for breast cancer and the clinical efficacy of ondansetron hydrochloride tablets].[乳腺癌化疗门诊患者呕吐发生率及盐酸昂丹司琼片的临床疗效]
Gan To Kagaku Ryoho. 2002 May;29(5):723-8.
7
[Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer].盐酸雷莫司琼在乳腺癌CMF或CEF方案化疗中对恶心呕吐的防治作用
Gan To Kagaku Ryoho. 1999 Jul;26(8):1163-70.
8
Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo.
Am J Clin Oncol. 1989 Dec;12(6):524-9. doi: 10.1097/00000421-198912000-00014.
9
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
Gan To Kagaku Ryoho. 2002 Feb;29(2):273-9.
10
[Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer].
Gan To Kagaku Ryoho. 1997 Jul;24(9):1095-101.

引用本文的文献

1
[Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].[化疗引起的呕吐的管理：经过20年临床研究后何为标准]
Med Klin (Munich). 1998 Jan;93 Suppl 1:3-17. doi: 10.1007/BF03041988.
2
Antiemetics in cancer chemotherapy: historical perspective and current state of the art.癌症化疗中的止吐药：历史回顾与当前技术水平
Support Care Cancer. 1994 May;2(3):150-60. doi: 10.1007/BF00417473.
3
Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities.减轻化疗引起的恶心和呕吐。当前观点与未来可能性
Drug Saf. 1993 Dec;9(6):410-28. doi: 10.2165/00002018-199309060-00004.
4
Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient.口服昂丹司琼（GR 38032F）用于控制门诊患者中CMF诱导的呕吐。
Breast Cancer Res Treat. 1991 Oct;19(2):129-32. doi: 10.1007/BF01980943.